An fMRI-study on the Effects of 3'-Aminomethylnicotine-P. Aeruginosa r-Exoprotein a Conjugate Vaccine (NicVAX) and Placebo on Central Nervous System Activation and Behaviour Following a Nicotine Challenge

Trial Profile

An fMRI-study on the Effects of 3'-Aminomethylnicotine-P. Aeruginosa r-Exoprotein a Conjugate Vaccine (NicVAX) and Placebo on Central Nervous System Activation and Behaviour Following a Nicotine Challenge

Completed
Phase of Trial: Phase I/II

Latest Information Update: 01 Mar 2013

At a glance

  • Drugs Nicotine abuse vaccine (Primary)
  • Indications Smoking withdrawal
  • Focus Pharmacodynamics
  • Most Recent Events

    • 25 Mar 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top